Abstract
Background
Family physicians play an important role in coordinating care for medically complex patients, especially during the end-of-life (EOL) period. While continuity of care (COC) is a routinely measured care quality indicator, the influence of geographic proximity to family physicians on EOL COC has not been studied in the Canadian context. Existing research has focused on rurality indicators instead of individual-level proximity measures.
Objectives
This study objectives are to: (1) measure the association between patients’ geographic proximity to their family physician and COC during the patients’ last year of life; and (2) measure the association between geographic proximity and the number of days spent in the community and palliative homecare services referral in the last year of life, and place of death.
Methods
We will conduct a population-level retrospective cohort study using linked health administrative data from ICES in Ontario, Canada, of adults who died between January 1, 2021, and December 31, 2024. Geographic proximity to the rostered family physician will be calculated in the shortest travel distance and time from the patient’s residence to the physicians primary practice location, considering road, transit, and walking infrastructure. COC will be measured using three indices: Usual Provider of Care, Modified Bice-Boxerman, and Relative Variance indices, based on outpatient visits in the last year of life. EOL outcomes will include days spent in the community, referral to palliative home care, and place of death. Multivariate regression will measure associations between proximity and outcomes, adjusting for relevant patient-level characteristics.
Expected outcomes
We hypothesize that patients living closer to their family physician will experience higher COC and improved healthcare outcomes at the end of life. Findings have the potential to inform health policy and planning aimed at improving equitable geographic access to family medicine during the late stages of life.
Citation: Hafid S, Mbuagbaw L, Newbold B, Costa A, Gayowsky A, Gozdyra P, et al. (2025) Measuring geographic proximity and continuity with family medicine at end-of-life: Protocol for a population-level retrospective cohort study using Canadian Health Administrative Data. PLoS One 20(12): e0336790. https://doi.org/10.1371/journal.pone.0336790
Editor: Avanti Dey, Public Library of Science, UNITED STATES OF AMERICA
Received: October 22, 2025; Accepted: October 31, 2025; Published: December 4, 2025
Copyright: © 2025 Hafid et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.
Funding: This work is funded by a Canadian Institutes of Health Research project grant (#180345).
Competing interests: The authors have declared that no competing interests exist.
1. Introduction
1.1. Background
Family medicine plays a critical role in healthcare provision for individuals in Ontario, especially facilitating specialist referrals and coordinating care for medically complex patients [1–4]. This relationship is relevant at the end of life as family physicians account for approximately 65% of outpatient visits during the last year of life among patients who died in Ontario, Canada, between 2013 and 2017 [5]. The same study also identified that patients receive outpatient care from multiple physicians across four unique specialties during the last year of life. The concentration of outpatient care among family medicine reinforces the belief that family physicians are responsible for most outpatient end-of-life (EOL) care, by potentially coordinating their patients’ care across different providers.
Continuity of care (COC) is also foundational to high-quality healthcare provision, specifically for patients with medical complexity such as those at the end of life. Haggerty et al. defined continuity of care as “the degree to which a series of discrete healthcare events is experienced as coherent and connected and consistent with the patient’s medical needs and personal context” [6,7]. The unique relationship between patients and their family physicians may enhance continuity by fostering trust during difficult periods such as the end of life [6]. This complements our understanding of EOL outpatient visit concentration with family physicians.
Although continuity is extensively studied in both quantitative and qualitative health services research, the relationship between a patient’s geography is often overlooked as a predictor for outpatient care use, and subsequently continuity. Specifically, health services research has typically only considered patients rurality status, by means of categorical variables demarcating whether patients reside in urban or rural regions. For example, our previous study aimed at identifying the patient-level characteristics associated higher continuity during the last year of life, only included the patients’ residential rurality status (as a dichotomized variable measuring if a patient resided in an urban or rural region) as a predictor [8]. Other approaches that have been used are the Population Centre (POPCTR) method, the Statistical Area Classification (SAC), or the Rurality Index of Ontario (RIO) score [9]. The POPCTR method categorizes census metropolitan areas and census agglomerations into three categories (small, medium, and large urban centres), based on the population size and density of the census geographic unit. The SAC method also categorizes census boundaries into classifications; however, it is based on the percentage of the workforce that is composed of residents. Lastly, the RIO score is the most appropriate for healthcare as it produces a continuous score derived from population and population density, the travel time to the nearest basic referral centre (i.e., general inpatient hospitals), and the travel time to the nearest advanced referral centre (i.e., cancer care centres) [10]. While these approaches provide rich information regarding the effects of rurality on care use, they do not consider the impacts of patients’ geographic proximity to their family physicians as they do not measure the distance between the patients and their corresponding family physician at the individual-level.
1.2. Research gap
There is a significant evidence gap regarding the relationship patients’ geographic proximity to their family physicians and their EOL care. For example, Kelly et al. conducted a systematic review of 108 studies from high-income countries examining the association between travel time or distance to healthcare providers and health outcomes. None of these studies focused specifically on the EOL context, which is concerning as this period of life is often associated with an escalation of care [5]. Moreover, only three studies examined distance to family physicians, and all were conducted in the United States. Specifically, one study assessed the relationship between driving time to family physicians and timely cancer diagnosis and treatment [11], while the other two explored proximity to family physicians and health outcomes for patients with diabetes [12,13].
Although these studies did not address EOL care, Kelly et al.’s review identified a consistent ‘distance decay’ effect, where patients living further from their healthcare providers experienced poorer outcomes compared to patients who lived closer. Similarly, a separate literature review of 27 studies on travel burden for cancer diagnosis and treatment also found evidence of distance decay associations [14], yet only one study is from Canada [15]. Overall, very few studies have examined the proximity and healthcare use in the Canadian context, and most have focused on outcomes typically associated with specialist or inpatient care. To date, no studies have specifically investigated this relationship in the Canadian EOL setting.
1.3. Study objectives and hypothesis
The study objectives include: 1) to measure the association between the patients’ geographic proximity to their family physician and their relational COC with their family physician during the last year of life; and 2) to study the association between the patients’ geographic proximity to their family physician and relevant EOL healthcare outcomes.
This research will address a tangible aspect of access to care that is often simplified using rurality indicators and has not been explored in a Canadian context, despite the growing importance of family medicine access and the aging population. Understanding this relationship can help inform future health policy initiatives aimed at improving access to EOL healthcare. As such, we hypothesize that patients living closer to their family physician will experience higher continuity of care during the EOL and, as such, will also experience improved EOL healthcare outcomes.
2. Methods
2.1. Data sources
This study will used linked health administrative data from ICES, formerly known as the Institute for Clinical Evaluative Sciences. ICES is an independent, non-profit research institute funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC). As a prescribed entity under Ontario’s privacy legislation, ICES is authorized to collect and use health care data for the purposes of health system analysis, evaluation and decision support. Secure access to these data is governed by policies and procedures that are approved by the Information and Privacy Commissioner of Ontario.
2.2. Study design and population
This protocol was designed in alignment with the RECORD (Reporting of studies Conducted using Observational Routinely collected Data) statement [16]. We will use data from ICES to conduct a population-level retrospective cohort study of adult patients who died in Ontario, Canada, between January 1, 2021 and December 31, 2024. Cohort exclusion criteria include: 1) pediatric decedents (<19 years of age at death) to ensure that pediatric outpatient visits are not included in the analysis; 2) individuals with insufficient number of outpatient visits to their FP during the observation period (<3 visits) in order to calculate the relational COC indices; 3) individuals who changed residence during the exposure period, to mitigate geographic inconsistencies; 4) individuals ineligible for the Ontario Health Insurance Plan (OHIP) at any point in the exposure or observation periods; 5) admission to a long-term care facility within the last year of life as long-term care residents experience an institution-driven model of care where most of their care provision is provided by, often multiple, physicians attending their long-term care facilities; and 6) patients aged 105 years at death or older to prevent potential documented errors in date of birth information. As this will be a population-level analysis, all eligible individuals will be included in the cohort for analysis. Therefore, we can anticipate a very large sample size, as previous research identified approximately 360,000 decedents in Ontario between 2013 and 2017 [5].
2.3. Exposure definition
The primary exposure variable will be the patient’s geographic proximity to their formally rostered family physician at one year before death, measured in two units: metres (kilometres) and minutes (hours) (see section 2.6.1 Sensitivity Analyses for more detail).
First, the patient’s rostered family physician will be identified using the Client Agency Program Enrolment (CAPE) dataset, which records patients formally attached to a family physician under a capitation-based model. Patients without a formal attachment will be virtually rostered to the family physician with the greatest number of primary care-relevant OHIP billing codes in the two years preceding the last year of life [17].
Second, we will determine the patient’s most recent 6-digit postal code at one year before death using the Registered Persons Database and their corresponding family physician’s 6-digit postal code from the Corporate Physician Database. To minimize mis-classification due to large postal code boundaries, particularly in rural regions in Northern Ontario, we will use Statistics Canada’s Postal Code Conversion File+ (PCCF+) [18]. PCCF+ enables calculation of population-weighted centroids for each postal code boundary, by linking postal codes to all associated dissemination areas and applying population weights. This approach ensures that the identified centroids reflect actual residential distributions instead of the geometric centres of the boundaries – addressing the absence of individual-level address data for both patients and physicians due to privacy concerns. See below the equation for producing population-weighted centroids:
where DA are the individual dissemination areas linked to the postal code using PCCF+ and Population Weight is the proportion of the population within the dissemination area for that postal code.
Finally, we will use ArcGIS [19] Network Analyst with Ontario road, public transit, and walking path network data to calculate the shortest distance and travel time between the weighted centroid pairs [20]. The shortest routes across all three transportation modes will be defined as geographic proximity and will subsequently be categorized into empirical quartiles for analysis. This is a novel approach that provide a realistic measure of the travel burden experienced by patients instead of relying on the Euclidean distance (i.e., birds eyeview distance) between two geographic coordinates [21].
2.4. Outcome definitions
2.4.1. Association between geographic proximity and EOL continuity.
We will use three relational COC indices (Appendix 1 in S1 File for their equations) when measuring the effect of geographic proximity to one’s family physician and continuity at the end of life:
- The Usual Provider of Care (UPC) index measures the concentration of visits to a single provider out of all provider visits [22]. For this study, the rostered family physician will be pre-specified as the usual provider [8,23]. UPC scores range from 0 to 1, where 1 indicates all visits were to the rostered family physician.
- The Modified Bice-Boxerman (BB) index expands on the unmodified BB index [24] by measuring the degree of the dispersion within each specialty instead of across specialties [25]. This index also ranges from 0 to 1, where 1 indicates all visits within each specialty were to the same physician.
- The relative variance index (RVI), also known as the regularity index, measures the consistency of visit intervals to a single provider [26]. As such, we will measure the visit interval consistency with the rostered family physician and the index ranges from 0 to 1, where 1 indicates perfectly regular visit intervals.
All three indices will be calculated using outpatient visits during the patient’s last year of life, defined as all OHIP physician billing claims with location codes “Office”, “Phone”, or “Home”. Each index will also be categorized into empirical quartiles for analysis. All continuity index calculations will exclude billing claims from specialties not typically involved in the ongoing management of a patient’s condition, such as emergency medicine, anesthesiology, or pathology. Appendix 2 in S1 File provides a list of physician specialties to be excluded.
2.4.2. Association between geographic proximity and EOL healthcare outcomes.
To study the impact of geographic proximity on EOL healthcare outcomes, the following outcomes will be studied:
- Number of days spent in the community during the last year of life and the last 90 and 30 days of life.
- Referral to palliative home care services during the last year of life and the last 90 and 30 days of life.
- Place of death, categorized as acute care facility, sub-acute facility, or community.
Number of days spent in the community will be captured using Inpatient hospitalizations will be identified using the Discharge Abstract Database (DAD), ED visits using the National Ambulatory Care Reporting System (NACRS), and place of death using an ICES-derived macro [27,28] that considers multiple administrative datasets: 1) acute care deaths: DAD, NACRS, Same Day Surgery (SDS); 2) sub-acute deaths: Continuing Care Reporting System – Complex Continuing Care (CCRS-CCC), National Rehabilitation System (NRS), Ontario Mental Health Reporting System (OMHRS); and 3) community deaths: all other locations not captured in the previously holdings.
2.5. Covariates
Several patient-level demographic and clinical characteristics will be captured at one year before death (unless otherwise specified):
- Age may affect the number of visits a patient may have in the last year, with evidence to suggest that seniors are more likely to visit their family physician [29]. Additionally, there is the possibility that younger patients move away further from the family physician due to increased costs of living, especially in large urban regions [30].
- Sex will be included as there is evidence that female patients access more EOL care [31] and experience higher EOL COC [8], compared to males.
- Rurality status will be included previous research also identified that patients living in urban regions were more likely to receive EOL care [31], yet patients living in rural regions were more likely to experience higher EOL COC [8].
- Socioeconomic status, as patients with lower socioeconomic status may have decreased access to primary care physicians by relying on fee-for-service walk-in clinics over formal primary care teams.28
- Comorbidity status will be measured using the number of prevalent Johns Hopkins Adjusted Clinical Groups [32], as patients with higher comorbidity burden may require more visits with their providers during at the end of life [31].
- Cancer status will be measured as whether patients received any active cancer treatments (i.e., chemotherapy [33–36], surgeries [37,38], or radiation therapy [36]) during the last year of life. We want to control for active cancer treatment as patients dying of cancer receive greater access to palliative care at the end of life compared to patients who die of other conditions [8,23,31].
2.6. Statistical analysis
Patient demographic and clinical characteristics will be summarized using means and standard deviations for normally distributed continuous variables, or medians with interquartile ranges (25th and 75th percentiles) for non-normally distributed variables. Counts and percentages will be reported for categorical variables. Baseline characteristics will be stratified by quartiles of geographic proximity to assess differences across exposure levels. Differences will be tested using independent samples t-tests and Pearson’s Chi-square tests for continuous and categorical variables, respectively. Effect sizes will also be measured using Cohen’s d and Cramer’s V for continuous and categorical variables, respectively.
Study outcomes will be summarized using means (standard deviations), medians (interquartile ranges), and counts (percentages) across the entire cohort and stratified by exposure quartiles. Next, we will use regression analysis to examine associations between geographic proximity and study outcomes, adjusting for all previously specified covariates:
- Continuity outcomes (quartiles): Cumulative link proportional-odds ordinal regression.
- EOL healthcare outcomes (count-based): Poisson regression, or negative binomial regression with a log-link function if overdispersion is present.
- Place of death (categorical): Multinomial logistic regression with a logit-link.
Statistical significance will be assessed at p < 0.001 (two-tailed) to account for the anticipated large sample size. All effect sizes and model coefficients will be reported with 95% confidence intervals, and all analyses will be conducted using Python [39].
2.7. Study status and timeline
This study is a retrospective cohort analysis using routinely collected health administrative data for the purpose of evaluating, monitoring and planning of the health care system. Therefore, participant recruitment is not applicable. Data collection involves the extraction and linkage of deidentified health administrative data; data collection and analysis has not yet commenced as of November 2025 Results from are expected to be available by May 2026.
3. Data management and quality assurance
Administrative datasets will be accessed using server connections and all linked datasets will be held in coded format in a secure research environment at ICES McMaster. Only the lead investigator and analytic epidemiologist at ICES McMaster will have access to the linked datasets to be used for analysis and will be responsible for data management and retention. However, the Python programming scripts for the analysis will be available upon request for potential replication analyses.
4. Ethics and privacy
Research projects that only use data collected by ICES are exempt from research ethics board review under section 45 of Ontario’s Personal Health Information Protection Act. Section 45 authorizes ICES to collect personal health information, without consent, for analyzing data to manage, evaluate, or monitor, the healthcare system. The use of this data is also approved by ICES’ Privacy and Legal Office. Therefore, this study does not require individual consent as this would also be pragmatically impossible given the study cohort of interest. In addition, the use of existing and routinely collected data poses minimal risk of harm to patients included in the study cohort. Further, ICES enforces a rigorous risk identification process when exporting research outputs to ensure that small cell issues are suppressed in research outputs, to eliminate the risk of re-identification.
5. Strengths and limitations
This study design has several strengths. First, this study utilizes a novel methodology, specifically geographic network analysis, which is not extensively used in health services research in Ontario. Geographic network analysis enables us to capture the individual-level travel burden patients experience, and in turn, providing a much more nuanced measure of travel burden or geographic access compared to the existing approaches commonly used in health services research. Second, the use of population-level data has several strengths, such as improving internal validity by capturing all documented healthcare interactions, ensuring that a wide variety of patients, such as both low and high healthcare users, are captured. Additionally, using population-level data increases the external validity of our potential results as we will include virtually all decedents from Ontario Between 2021 and 2024. Therefore, our potential findings may also be relevant to other jurisdictions with universal healthcare systems that provide robust family medicine services.
However, using population-level health administrative data will also have limitations as well. First, there will always be a certain degree of residual confounding by using health administrative data. Key personal information such as the patient’s preferred or available transportation methods cannot be determined. Similarly, we cannot assess if a patient experiences mobility issues that forces them to use a specific transportation method, which may increase or decrease their travel burden. Second, there is a risk of misclassification bias and potential measurement error due to not being able to access both patients’ and physicians’ full geographic information (i.e., their full address) beyond the 6-digit postal code due to privacy and confidentiality legislation. We aim to mitigate this by using weighted population centroids within each 6-digit postal code boundary to approximate geographic proximity; however, the risk remains at the individual-level. Lastly, our analysis focuses specifically on patients’ geographic proximity to their family physicians, however, many patients may receive primary care from allied health professionals such as nurse practitioners. Therefore, our results will not assess the impact of allied health as this data is unavailable in health administrative data [40–42].
6. Conclusion
This study will generate novel insights into how geographic proximity to family physicians during the end-of-life period influences continuity of care and healthcare outcomes at this critical stage. By integrating advanced geospatial methodologies with validated continuity indices and population-level health administrative data, our design addresses a key gap in Canadian health services research. Findings will be submitted to peer-reviewed journals and presented at health policy–focused conferences to inform future planning and policy development. Through this work, we aim to promote equitable access to family medicine during the final stages of life, particularly for medically complex patients.
Acknowledgments
This study will be supported by ICES, which is funded by an annual grant from the Ontario MOH and the MLTC. This study will use data adapted from the Statistics Canada Postal CodeOM Conversion File, which is based on data licensed from Canada Post Corporation, and/or data adapted from the Ontario MOH Postal Code Conversion File, which contains data copied under license from ©Canada Post Corporation and Statistics Canada.
Parts of this study will be based on data and/or information compiled and provided by the Ontario MOH and Canadian Institute for Health Information. The analyses, conclusions, opinions, and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement is intended or should be inferred.
References
- 1. Easley J, Miedema B, O’Brien MA, Carroll J, Manca D, Webster F, et al. The role of family physicians in cancer care: perspectives of primary and specialty care providers. Curr Oncol. 2017;24(2):75–80. pmid:28490920
- 2. Easley J, Miedema B, Carroll JC, Manca DP, O’Brien MA, Webster F. Coordination of cancer care between family physicians and cancer specialists: Importance of communication. Canadian Family Physician. 2016;:e608–15.
- 3. Chaput G, Med CP, Sussman J. Integrating primary care providers through the seasons of survivorship. Curr Oncol. 2019;26(1):48–54. pmid:30853798
- 4. Henschen BL, Shaunfield S, Golden BP, Gard LA, Bierman J, Evans DB, et al. From Passive Gatekeeper to Quarterback: Evolving Perceptions of Primary Care Among Medical Students in Longitudinal Outpatient Clerkships. J Gen Intern Med. 2022;37(3):608–14. pmid:34100228
- 5. Howard M, Hafid A, Isenberg SR, Hsu AT, Scott M, Conen K, et al. Intensity of outpatient physician care in the last year of life: a population-based retrospective descriptive study. CMAJ Open. 2021;9(2):E613–22. pmid:34088732
- 6. Haggerty JL, Reid RJ, Freeman GK, Starfield BH, Adair CE, McKendry R. Continuity of care: a multidisciplinary review. BMJ. 2003;327(7425):1219–21. pmid:14630762
- 7. Haggerty JL, Roberge D, Freeman GK, Beaulieu C. Experienced continuity of care when patients see multiple clinicians: a qualitative metasummary. Ann Fam Med. 2013;11(3):262–71. pmid:23690327
- 8. Howard M, Hafid A, Webber C, Isenberg SR, Gayowsky A, Jones A, et al. Continuity of physician care over the last year of life for different cause-of-death categories: a retrospective population-based study. CMAJ Open. 2022;10(4):E971–80. pmid:36347560
- 9.
Ontario HQ. Geographic location methods review: summary report. 2019.
- 10.
Kralj B, Ontario Medical Association Economics D. Measuring rurality - RIO 2008_BASIC: methodology and results. Toronto, Ont.: Ontario Medical Association Economics Department. 2009. https://www.deslibris.ca/ID/237943
- 11. Scoggins JF, Fedorenko CR, Donahue SMA, Buchwald D, Blough DK, Ramsey SD. Is distance to provider a barrier to care for medicaid patients with breast, colorectal, or lung cancer?. J Rural Health. 2012;28(1):54–62. pmid:22236315
- 12. Littenberg B, Strauss K, MacLean CD, Troy AR. The use of insulin declines as patients live farther from their source of care: results of a survey of adults with type 2 diabetes. BMC Public Health. 2006;6:198. pmid:16872541
- 13. Strauss K, MacLean C, Troy A, Littenberg B. Driving distance as a barrier to glycemic control in diabetes. J Gen Intern Med. 2006;21(4):378–80. pmid:16686817
- 14. Ambroggi M, Biasini C, Del Giovane C, Fornari F, Cavanna L. Distance as a Barrier to Cancer Diagnosis and Treatment: Review of the Literature. Oncologist. 2015;20(12):1378–85. pmid:26512045
- 15. Lee B, Goktepe O, Hay K, Connors JM, Sehn LH, Savage KJ, et al. Effect of place of residence and treatment on survival outcomes in patients with diffuse large B-cell lymphoma in British Columbia. Oncologist. 2014;19(3):283–90. pmid:24569946
- 16. Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. pmid:26440803
- 17. Howard M, Chalifoux M, Tanuseputro P. Does Primary Care Model Effect Healthcare at the End of Life? A Population-Based Retrospective Cohort Study. J Palliat Med. 2017;20(4):344–51. pmid:27893954
- 18.
Canada S. Postal Code OM Conversion File Plus. Ottawa, ON: Government of Canada. 2023.
- 19.
ArcGIS Pro 3.1.2. United States of America: ESRI. 2023.
- 20. Sevtsuk A, Mekonnen M. Urban network analysis. A new toolbox for ArcGIS. Revue internationale de géomatique. 2012;22(2):287–305.
- 21. Crosby H, Damoulas T, Jarvis SA. Embedding road networks and travel time into distance metrics for urban modelling. International Journal of Geographical Information Science. 2018;33(3):512–36.
- 22. Reid RJ, Haggerty JL, McKendry R. Defusing the confusion: Concepts and measures of continuity of healthcare. Health Services Research Foundation. 2002;:258.
- 23. Howard M, Hafid S, Isenberg SR, Webber C, Downar J, Gayowsky A, et al. Physician continuity of care in the last year of life in community-dwelling adults: retrospective population-based study. BMJ Support Palliat Care. 2023;:spcare-2023-004357. pmid:37580116
- 24. Bice TW, Boxerman SB. A quantitative measure of continuity of care. Med Care. 1977;15(4):347–9. pmid:859364
- 25. Jones A, Bronskill SE, Bronskill SE, Seow H, Seow H, Junek M. Associations between continuity of primary and specialty physician care and use of hospital-based care among community-dwelling older adults with complex care needs. PLoS ONE. 2020;:1–16.
- 26. Youens D, Harris M, Robinson S, Preen DB, Moorin RE. Regularity of contact with GPs: Measurement approaches to improve valid associations with hospitalization. Fam Pract. 2019;36(5):650–6. pmid:30689822
- 27. Qureshi D, Tanuseputro P, Perez R, Pond GR, Seow HY. Early initiation of palliative care is associated with reduced late-life acute-hospital use: A population-based retrospective cohort study. Palliative Medicine. 2019;:150–9.
- 28. Tanuseputro P, Beach S, Chalifoux M, Wodchis WP, Hsu AT, Seow H, et al. Associations between physician home visits for the dying and place of death: A population-based retrospective cohort study. PLoS One. 2018;13(2):e0191322. pmid:29447291
- 29. Laporte A, Nauenberg E, Shen L. Aging, social capital, and health care utilization in Canada. Health Econ Policy Law. 2008;3(Pt 4):393–411. pmid:18793479
- 30.
Butler C. Ontario’s young adults are leaving the province in droves. The soaring cost of living is to blame. CBC News. 2023.
- 31. Seow H, O’Leary E, Perez R, Tanuseputro P. Access to palliative care by disease trajectory: a population-based cohort of Ontario decedents. BMJ Open. 2018;8(4):e021147. pmid:29626051
- 32. Austin PC, Shah BR, Newman A, Anderson GM. Using the Johns Hopkins’ Aggregated Diagnosis Groups (ADGs) to predict 1-year mortality in population-based cohorts of patients with diabetes in Ontario, Canada. Diabet Med. 2012;29(9):1134–41. pmid:22212006
- 33. Bremner KE, Yabroff KR, Coughlan D, Liu N, Zeruto C, Warren JL, et al. Patterns of Care and Costs for Older Patients With Colorectal Cancer at the End of Life: Descriptive Study of the United States and Canada. JCO Oncol Pract. 2020;16(1):e1–18. pmid:31647697
- 34. Eskander A, Krzyzanowska MK, Fischer HD, Liu N, Austin PC, Irish JC, et al. Emergency department visits and unplanned hospitalizations in the treatment period for head and neck cancer patients treated with curative intent: A population-based analysis. Oral Oncol. 2018;83:107–14. pmid:30098764
- 35. Cusimano MC, Baxter NN, Gien LT, Moineddin R, Liu N, Dossa F, et al. Impact of surgical approach on oncologic outcomes in women undergoing radical hysterectomy for cervical cancer. Am J Obstet Gynecol. 2019;221(6):619.e1-619.e24. pmid:31288006
- 36. Mittmann N, Cheng SY, Liu N, Seung SJ, Saxena FE, DeAngelis C, et al. The generation of two specific cancer costing algorithms using Ontario administrative databases. Curr Oncol. 2019;26(5):e682–92. pmid:31708661
- 37.
Quan ML, Hodgson N, Przybysz R, Gunraj N, Schultz SE, Baxter N. Cancer Surgery in Ontario: ICES Atlas. Toronto: Institute for Clinical Evaluative Sciences. 2008.
- 38.
Alter DA, Cohen EA, Wang X, Glasgow K. Access to Health Services in Ontario: ICES Atlas. Toronto: Institute for Clinical Evaluative Sciences. 2006.
- 39.
Python. Python Software Foundation. 2025.
- 40. Collins CM, Small SP. The nurse practitioner role is ideally suited for palliative care practice: A qualitative descriptive study. Can Oncol Nurs J. 2019;29(1):4–9. pmid:31148678
- 41. Côté N, Freeman A, Jean E, Denis J-L. New understanding of primary health care nurse practitioner role optimisation: the dynamic relationship between the context and work meaning. BMC Health Serv Res. 2019;19(1):882. pmid:31752860
- 42. Htay M, Whitehead D. The effectiveness of the role of advanced nurse practitioners compared to physician-led or usual care: A systematic review. Int J Nurs Stud Adv. 2021;3:100034. pmid:38746729